ScheduleDay 1: May 26 (Fri.), 2023

Room 1Room 2

Poster RoomMain Hall（5F）Large Hall（5F）

Foyer（5F）

8:00

9:00

10:00

11:00

12:00

13:00

14:00

15:00

Annual General Meeting of Members(Board of Delegates)
15:00 ‒ 16:00
16:00

17:00

Sponsored Seminar 1 17:00 ‒ 17:50
How should we deal for the cancer patientscomplicated with COVID-19
Chairperson: Kazuhito Suzuki
Speaker: Osamu Kobayashi【GlaxoSmithKline K.K.】

18:00

Sponsored Seminar 2 18:00 ‒ 18:50
Positioning of CD38 monoclonal antibody(Daratumumab) for the treatment of Multiple
Myeloma and Systemic AL Amyloidosis
Chairperson: Tadao Ishida
Speakers: Junya Kuroda, Shin-ichi Fuchida【Janssen Pharmaceutical K.K.】

19:00

ScheduleDay 2: May 27 (Sat.), 2023

Room 1Room 2

Poster RoomMain Hall（5F）Large Hall
（5F）

Foyer（5F）

8:00

9:00

10:00

11:00

Opening Ceremony 8:50 ‒ 9:00
Symposium 1
9:00 ‒ 10:15
New developments of immunotherapy

Oral Session 1
9:00 ‒ 10:05
NDMM Treatment-Transplant eligible/ineligible

Sponsored Seminar 3 10:25 ‒ 11:15
About the well-being of patients withmultiple myelomaSponsored Seminar 4 10:25 ‒ 11:15
Chromosomal abnormalities in multiple myeloma:
which ones to assess? With which technique?

Chairpersons: Yoichi Imai, Maiko Matsushita
Speakers: Yoichi Imai, Toshiki Ochi, Yuki Kagoya

Chairperson: Yotaro Tamai
Speakers: Yusuke Koba, Morio Matsumoto【ONO PHARMACEUTICAL CO., LTD.】

Poster Mounting
8:30 ‒ 10:00

Chairperson: Go Yamamoto

Chairperson: Naoki Hosen
Speaker: Hervé Avet-Loiseau【AbbVie GK】

Educational Lecture 1 11:20 ‒ 11:50
Management for multiple myeloma based on
updated guidelines
Chairperson: Shuji Ozaki Speaker: Shigeki Ito

12:00

Luncheon Seminar 1 12:00 ‒ 12:50
The signiﬁcance of the combination therapy ofdaratumumab and IMiDs for multiple myeloma
from scientiﬁc and clinical aspects
Chairperson: Chiaki Nakaseko
Speakers: Takeshi Harada, Yuichi Horigome【Janssen Pharmaceutical K.K.】

Luncheon Seminar 2 12:00 ‒ 12:50
The positioning of PI continuation therapy in
MM treatment sequence
Chairperson: Hirokazu Murakami
Speakers: Kenshi Suzuki, Naoki Takezako【Takeda Pharmaceutical Company Limited】

13:00

General Membership Meeting
13:00 ‒ 13:30

14:00Presidential Lecture 13:30 ‒ 14:00
Drug discovery for myeloma fromnew perspectives of pathophysiology

Symposium 2 14:10 ‒ 15:00
Molecular pathogenesis andtreatment of high-risk myeloma

15:00

Poster Viewing
10:00 ‒ 17:30

Chairperson: Masahiro Abe Speaker: Yutaka Hattori

Chairpersons: Akira Sakai, Yasushi Takamatsu
Speakers: Hervé Avet-Loiseau, Ichiro Hanamura

Oral Session 2
14:10 ‒ 15:15
Pathophysiology & Treatment (non-clinical) 1
Chairperson: Norifumi Tsukamoto

Special Lecture 1
15:10 ‒ 16:20
Cutting edge of biology in post-genome era16:00

17:00

Oral Session 3
15:25 ‒ 16:30
RRMM Treatment

Chairpersons: Yutaka Hattori, Mineo Kurokawa
Speakers: Ai Kotani, Noboru Mizushima

Sponsored Seminar 5 16:30 ‒ 17:20
Current status and issues of CAR-T cell therapy
for multiple myeloma in a routine practice
Chairperson: Junya Kuroda Speaker: Masaki Ri【Bristol-Myers Squibb K.K.】

Chairperson: Yuichi Nakamura

Oral Session 4
16:40 ‒ 17:20
Diagnostic Procedure (including bio-marker)
Chairperson: Michihide Tokuhira

Poster Session 1 Pathophysiology & Treatment (non-clinical)
Chairperson: Hiroshi Yasui

Poster Session 2 Diagnostic Procedure (including bio-marker)/Complications, Supportive Care and Comprehensive Care
18:00

Chairperson: Akihiro Yokoyama

Poster Session 3 NDMM Treatment-Transplant eligible/RRMM Treatment
Chairperson: Toru Kiguchi

Poster Session 4 Myeloma-related Disorders/Case Report 1
Chairperson: Taku Kikuchi

Poster Session 5 Case Report 2/Others
Encore (Poster Session)
19:00

Chairperson: Makoto Osada
Chairperson: Naoya Mimura

Poster Session
17:30 ‒ 18:30

ScheduleDay 3: May 28 (Sun.), 2023

8:00

Room 1Room 2

Poster Room

Main Hall（5F）Large Hall（5F）

Foyer（5F）

8:00 ‒ 8:40
Morning Seminar 1
Treatment strategies for Lymphoplasmacytic Lymphoma/
Waldenström's Macroglobulinemia -including ourexperiences treating Bing‒Neel syndrome-

8:00 ‒ 8:40
Morning Seminar 2
Response evaluation on patients undergoing anti-CD38 therapy, Daratumumaband Isatuximab, should be determined by the HYDRASHIFT assays

Chairperson: Naohiro Sekiguchi Speaker: Masuho Saburi【ONO PHARMACEUTICAL CO., LTD.】

Chairperson: Hiroyuki Takamatsu
Speaker: Kazunori Miyake【SEBIA JAPAN K.K.】

9:0010:00

11:00

Symposium 3
9:00 ‒ 10:05
International symposium: Progress in myeloma
therapy: current status and future perspective

Oral Session 5
9:00 ‒ 9:55
Pathophysiology & Treatment (non-clinical) 2/
Case Report

Sponsored Seminar 6
10:15 ‒ 11:05
CAR T-cell therapy for multiple myeloma

10:15 ‒ 11:05
Sponsored Seminar 7
Clinical Trial Evidence to Real-World Evidence

Chairpersons: Hiroshi Kosugi, Tadao Ishida
Speakers: Nikhil C. Munshi, Daryl Tan, Shinsuke Iida

Chairperson: Masahiro Abe Speaker: Satoshi Yoshihara【Janssen Pharmaceutical K.K.】

Symposium 4
11:15 ‒ 12:05
General management of myeloma patients
12:00

Chairpersons: Yasuhito Terui, Masaki Ri
Speakers: Hiroshi Akazawa, Shinichi Mizuno

Luncheon Seminar 3 12:15 ‒ 13:05
Two years have passed since the Sarclisa® havelaunched-Considering the position of Sarclisa
from the basic and clinical perspectives
13:00

Chairperson: Shuji Ozaki
Speakers: Yusuke Furukawa, Takashi Ikeda【Sanoﬁ K.K.】

Educational Lecture 2 13:15 ‒ 13:45
Pharmacokinetic aspects of drugs used for the treatment of myeloma
Chairpersons: Yutaka Hattori, Hironobu Hashimoto
Speaker: Hisakazu Ohtani

14:00

Special Lecture 2
13:50 ‒ 15:00
Up-to-date of COVID-19 clinics

15:00

Plenary Session
15:10 ‒ 16:15

Chairpersons: Masahiro Abe, Chiaki Nakaseko
Speakers: Kentaro Mizuhara, Haruya Okamoto,
Yusuke Inoue, Sae Matsuoka, Takeshi Harada

Closing Ceremony
16:15 ‒ 16:30

17:00

18:00

19:00

Chairperson: Hirohiko Shibayama
Speaker: Teruhito Takakuwa

Poster Viewing
8:00 ‒ 13:00【Takeda Pharmaceutical Company Limited】

Oral Session 6
11:15 ‒ 12:10
Myeloma-related Disorders/OthersChairperson: Sho Ikeda

Luncheon Seminar 4 12:15 ‒ 13:05
Treatment Sequence considering Tumor andthe Immune Microenvironment
Chairperson: Kazutaka Sunami
Speakers: Michiko Ichii, Hideto Tamura【Bristol-Myers Squibb K.K.】

Encore (Oral Session) 1
13:15 ‒ 14:10

Chairpersons: Emiko Sakaida, Eri Matsuki

Chairpersons: Hiroshi Handa, Takahide Kikuchi
Speakers: Norio Ohmagari, Masao Hagihara

16:00

Chairperson: Jiro Kikuchi

Encore (Oral Session) 2
14:15 ‒ 15:10

Chairpersons: Makoto Sasaki, Nobuhiro Tsukada

Poster Withdrawal
13:00 ‒ 17:00